UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bacterial outer membrane vesicles and vaccine applications

Frontiers in immunology, 2014-03, Vol.5, p.121-121

2014

Volltextzugriff (PDF)

SARS-CoV‑2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

ACS chemical biology, 2021-07, Vol.16 (7), p.1223-1233

2021

Volltextzugriff (PDF)

Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines

ACS central science, 2021-05, Vol.7 (5), p.757-767

2021

Volltextzugriff (PDF)

Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa

Pharmacological research, 2017-07, Vol.121, p.194-201

2017

Volltextzugriff (PDF)

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles

RSC chemical biology, 2022-02, Vol.3 (2), p.242-249

2022

Volltextzugriff (PDF)

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

International journal of infectious diseases, 2023-01, Vol.126, p.164-173

2023

Volltextzugriff (PDF)

Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG

Asian Pacific journal of tropical biomedicine, 2017-03, Vol.7 (3), p.188-192

2017

Volltextzugriff (PDF)

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae

Vaccine, 2011-08, Vol.29 (34), p.5758-5764

2011

Volltextzugriff (PDF)

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice

Methods (San Diego, Calif.), 2009-12, Vol.49 (4), p.309-315

2009

Volltextzugriff (PDF)

Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats

Vaccine, 2011-04, Vol.29 (19), p.3596-3599

2011

Volltextzugriff (PDF)

Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats

Toxicology (Amsterdam), 2022-04, Vol.471, p.153161-153161, Article 153161

2022

Volltextzugriff (PDF)

Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles

Journal of microencapsulation, 2014-01, Vol.31 (1), p.86-92

2014

Volltextzugriff (PDF)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis

Human vaccines & immunotherapeutics, 2015, Vol.11 (3), p.657-661

2015

Volltextzugriff (PDF)

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG

BMC immunology, 2013, Vol.14 Suppl 1 (Suppl 1), p.S7-S7, Article S7

2013

Volltextzugriff (PDF)

A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models

BMC immunology, 2013, Vol.14 Suppl 1 (Suppl 1), p.S8-S8, Article S8

2013

Volltextzugriff (PDF)

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves

Human vaccines & immunotherapeutics, 2018-01, Vol.14 (9), p.2208-2213

2018

Volltextzugriff (PDF)

Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae

Travel medicine and infectious disease, 2013-03, Vol.11 (2), p.103-109

2013

Volltextzugriff (PDF)

Vacunas contra rotavirus: estado actual y tendencias futuras

Vaccimonitor, 2016-12, Vol.25 (3), p.89-97

2016

Volltextzugriff (PDF)

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation

Clinical and Experimental Vaccine Research , 2016, 5(2), , pp.175-178

2016

Volltextzugriff (PDF)

Synthesis of oligosaccharides from terminal B. pertussis LPS pentasaccharide and definition of the minimal epitope recognized by anti-pertussis antibodies

Glycoconjugate journal, 2024-07

2024

Volltextzugriff (PDF)

Reactividad de sueros de ratones inmunizados con vesículas de membrana externa derivadas de Salmonella entérica

Vaccimonitor, 2021-02, Vol.30 (1), p.33-38

2021

Volltextzugriff (PDF)

Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice

Vaccine, 2011-08, Vol.29 (37), p.6236-6241

2011

Volltextzugriff (PDF)

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

Vaccine, 2022-07, Vol.40 (31), p.4220-4230

2022

Volltextzugriff (PDF)

Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis model

Tuberculosis (Edinburgh, Scotland), 2016-12, Vol.101, p.44-48

2016

Volltextzugriff (PDF)

Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines

ACS central science, 2021-04, Vol.7, p.757-767

2021

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bacterial outer membrane vesicles and vaccine applications

SARS-CoV‑2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines

Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice

Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats

Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats

Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG

A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves

Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae

Vacunas contra rotavirus: estado actual y tendencias futuras

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation

Synthesis of oligosaccharides from terminal B. pertussis LPS pentasaccharide and definition of the minimal epitope recognized by anti-pertussis antibodies

Reactividad de sueros de ratones inmunizados con vesículas de membrana externa derivadas de Salmonella entérica

Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis model

Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines

Suchergebnisse filtern